Statistics for Characterization of TRIB2 mediated drug resistance and its validation as a novel diagnostic marker
Total visits
| views | |
|---|---|
| Characterization of TRIB2 mediated drug resistance and its validation as a novel diagnostic marker | 75 |
Total visits per month
| views | |
|---|---|
| July 2025 | 0 |
| August 2025 | 0 |
| September 2025 | 0 |
| October 2025 | 1 |
| November 2025 | 0 |
| December 2025 | 0 |
| January 2026 | 0 |
File Visits
| views | |
|---|---|
| sm_tese.pdf | 138 |
Top country views
| views | |
|---|---|
| Portugal | 24 |
| United States | 12 |
| Spain | 6 |
| Canada | 4 |
| China | 4 |
| United Kingdom | 4 |
| Hong Kong SAR China | 3 |
| Australia | 2 |
| Germany | 2 |
| Iran | 2 |
| Bangladesh | 1 |
| Switzerland | 1 |
| Ireland | 1 |
| India | 1 |
| South Korea | 1 |
| Poland | 1 |
| Palestinian Territories | 1 |
| Taiwan | 1 |
Top city views
| views | |
|---|---|
| Barcelona | 4 |
| Faro | 4 |
| Moncarapacho | 2 |
| Hebron | 1 |
| Lagos | 1 |
| Lisbon | 1 |
| Madrid | 1 |